Innospec Valuation
| IOSP Stock | USD 81.41 0.31 0.38% |
At this time, the firm appears to be fairly valued. Innospec retains a regular Real Value of $79.79 per share. The prevalent price of the firm is $81.41. Our model calculates the value of Innospec from evaluating the firm fundamentals such as Return On Asset of -7.0E-4, current valuation of 1.8 B, and Return On Equity of -9.0E-4 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Innospec's valuation include:
Price Book 1.5552 | Enterprise Value | Enterprise Value Ebitda 9.1273 | Price Sales 1.1342 | Forward PE 14.6413 |
Fairly Valued
Today
Please note that Innospec's price fluctuation is very steady at this time. Calculation of the real value of Innospec is based on 3 months time horizon. Increasing Innospec's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Innospec's intrinsic value may or may not be the same as its current market price of 81.41, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 81.41 | Real 79.79 | Target 99.33 | Hype 81.42 | Naive 81.43 |
The intrinsic value of Innospec's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Innospec's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Innospec helps investors to forecast how Innospec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innospec more accurately as focusing exclusively on Innospec's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Innospec's intrinsic value based on its ongoing forecasts of Innospec's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Innospec's closest peers.
Innospec Cash |
|
Innospec Revenue by Product
Innospec Total Value Analysis
Innospec is currently projected to have valuation of 1.8 B with market capitalization of 2.03 B, debt of 44.9 M, and cash on hands of 71.4 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innospec fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.8 B | 2.03 B | 44.9 M | 71.4 M |
Innospec Investor Information
About 100.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.56. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec recorded a loss per share of 0.04. The entity last dividend was issued on the 18th of November 2025. The firm had 2:1 split on the 23rd of July 2007. Based on the measurements of operating efficiency obtained from Innospec's historical financial statements, Innospec may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.11 | 0.0964 |
|
| |||||
| Total Cash From Operating Activities | 108.1 M | 212.2 M |
|
| |||||
| Operating Income | 214.8 M | 204.6 M |
|
|
Innospec Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Innospec connotes not a very effective usage of assets in January.Innospec Profitability Analysis
Based on the measurements of profitability obtained from Innospec's financial statements, Innospec's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Innospec's ability to earn profits and add value for shareholders.Net Income | First Reported 1998-03-31 | Previous Quarter 23.5 M | Current Value 12.9 M | Quarterly Volatility 19.4 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.39 | 0.34 |
|
| |||||
| Net Profit Margin | 0.0165 | 0.0174 |
|
| |||||
| Operating Profit Margin | 0.11 | 0.0964 |
|
| |||||
| Pretax Profit Margin | 0.0244 | 0.0257 |
|
| |||||
| Return On Assets | 0.0175 | 0.0185 |
|
| |||||
| Return On Equity | 0.0251 | 0.0265 |
|
|
For Innospec profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innospec to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innospec utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innospec's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innospec over time as well as its relative position and ranking within its peers.
Innospec Earnings per Share Projection vs Actual
The next projected EPS of Innospec is estimated to be 1.3925 with future projections ranging from a low of 1.3875 to a high of 1.4. Innospec's most recent 12-month trailing earnings per share (EPS TTM) is at -0.04. Please be aware that the consensus of earnings estimates for Innospec is based on EPS before non-recurring items and includes expenses related to employee stock options.Innospec Earnings Estimation Breakdown
The calculation of Innospec's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Innospec is estimated to be 1.3925 with the future projection ranging from a low of 1.3875 to a high of 1.4. Please be aware that this consensus of annual earnings estimates for Innospec is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.39 Lowest | Expected EPS | 1.40 Highest |
Innospec Earnings Projection Consensus
Suppose the current estimates of Innospec's value are higher than the current market price of the Innospec stock. In this case, investors may conclude that Innospec is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Innospec's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 3 | 87.4% | 0.0 | 1.3925 | -0.04 |
Innospec Ownership Allocation
Innospec has a total of 24.78 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Also note that almost two hundred twenty-five thousand four hundred seventy-six invesors are currently shorting Innospec expressing very little confidence in its future performance.Innospec Profitability Analysis
The company reported the previous year's revenue of 1.85 B. Net Income was 35.6 M with profit before overhead, payroll, taxes, and interest of 501.2 M.Innospec Past Distributions to stockholders
About Innospec Valuation
The stock valuation mechanism determines Innospec's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Innospec based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innospec. We calculate exposure to Innospec's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innospec's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 624.3 M | 329.4 M | |
| Pretax Profit Margin | 0.03 | 0.02 | |
| Operating Profit Margin | 0.10 | 0.11 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.34 | 0.39 |
Innospec Quarterly Retained Earnings |
|
A single share of Innospec represents a small ownership stake in the entity. As a stockholder of Innospec, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Innospec Dividends Analysis For Valuation
At this time, Innospec's Dividends Paid is relatively stable compared to the past year. As of 01/31/2026, Dividend Payout Ratio is likely to grow to 1.03, while Dividend Yield is likely to drop 0.01. . At this time, Innospec's Retained Earnings are relatively stable compared to the past year. As of 01/31/2026, Price Earnings Ratio is likely to grow to 72.84, while Retained Earnings Total Equity is likely to drop slightly above 628.1 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 44.6 M | 46.9 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.98 | 1.03 | |
| Dividend Paid And Capex Coverage Ratio | 2.65 | 2.51 |
There are various types of dividends Innospec can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Innospec shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Innospec directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Innospec pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Innospec by the value of the dividends paid out.
Innospec Growth Indicators
Investing in growth stocks can be very risky. If the company such as Innospec does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.1 M | |
| Quarterly Earnings Growth Y O Y | -0.609 | |
| Forward Price Earnings | 14.6413 |
Innospec Current Valuation Indicators
Innospec's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Innospec's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Innospec, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Innospec's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Innospec's worth.Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.